Evidence map›Paper›PMID 37128350›Full record

ArticleHeliyon2023

Ecotoxicity attenuation by acid-resistant nanofiltration in scandium recovery from TiO

Ildikó Fekete-Kertész, Tamás Stirling, Emese Vaszita, Zsófia Berkl, Éva Farkas, Sebastian Hedwig, Kirsten Remmen, Markus Lenz, Mónika Molnár, Viktória Feigl

Abstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ildikó Fekete-KertészBudapest University of Technology and Economics, Department of Applied Biotechnology and Food Science, H-1111 Budapest, Műegyetem rkp. 3, Hungary.
Tamás StirlingInstitute of Biochemistry, Szeged Biological Research Centre, 6726 Szeged, Hungary.
Emese VaszitaBudapest University of Technology and Economics, Department of Applied Biotechnology and Food Science, H-1111 Budapest, Műegyetem rkp. 3, Hungary.
Zsófia BerklBudapest University of Technology and Economics, Department of Applied Biotechnology and Food Science, H-1111 Budapest, Műegyetem rkp. 3, Hungary.
Éva FarkasBudapest University of Technology and Economics, Department of Applied Biotechnology and Food Science, H-1111 Budapest, Műegyetem rkp. 3, Hungary.
Sebastian HedwigInstitute for Ecopreneurship, University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, 4132, Muttenz, Switzerland.
Kirsten RemmenInstitute for Ecopreneurship, University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, 4132, Muttenz, Switzerland.
Markus LenzInstitute for Ecopreneurship, University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, 4132, Muttenz, Switzerland.
Mónika MolnárBudapest University of Technology and Economics, Department of Applied Biotechnology and Food Science, H-1111 Budapest, Műegyetem rkp. 3, Hungary.
Viktória FeiglBudapest University of Technology and Economics, Department of Applied Biotechnology and Food Science, H-1111 Budapest, Műegyetem rkp. 3, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lack of high-grade scandium (Sc) ores and recovery strategies has stimulated research on the exploitation of non-ore-related secondary sources that have great potential to safeguard the critical raw materials supply of the EU's economy. Waste materials may satisfy the growing global Sc demand, specifically residues from titanium dioxide (TiO

Indexed as

Acid-resistant nanofiltrationCritical raw materialsDirect toxicity assessmentEcotoxicity toolkitEnvironmental efficiencyWaste valorisation

Identifiers

PMID37128350
PMCPMC10148044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.